Liying Dong

No ORCID on file · 4 papers in corpus · active 2017-2024

Study types

  • other 2
  • article 1
  • rct 1

Condition tags

  • endometriosis 4
  • chronic_pelvic_pain 3
other 2024
Vilaprisan for the treatment of symptomatic endometriosis: results from a terminated phase 2b randomized controlled trial
F&S reports ·doi:10.1016/j.xfre.2024.03.002

OBJECTIVE: To evaluate the efficacy and safety of 2 doses of vilaprisan vs. placebo in participants with symptomatic endometriosis. DESIGN: Multicenter, randomized, double-blind, placebo-controlled, parallel-group phase 2b trial (NCT035733…

rct 2019
Dienogest for Treatment of Endometriosis in Women: A 28-Week, Open-Label, Extension Study
Journal of women's health (2002) ·doi:10.1089/jwh.2018.7084

BACKGROUND: Dienogest provided significantly greater reduction in endometriosis-associated pelvic pain (EAPP) than placebo in a 24-week, randomized, double-blind study of Chinese women with endometriosis. The current open-label extension st…

other 2017
Dienogest 2 mg Daily in the Treatment of Adolescents with Clinically Suspected Endometriosis: The VISanne Study to Assess Safety in ADOlescents
Journal of pediatric and adolescent gynecology ·doi:10.1016/j.jpag.2017.01.014

STUDY OBJECTIVE: To study the safety and efficacy of dienogest 2 mg in adolescents with suspected endometriosis. DESIGN: A 52-week, open-label, single-arm study. SETTING: In 21 study centers, in 6 European countries. PARTICIPANTS: Adoles…

article 2017
Dienogest for Treatment of Endometriosis in Chinese Women: A Placebo-Controlled, Randomized, Double-Blind Phase 3 Study
Journal of women's health (2002) ·doi:10.1089/jwh.2017.6399

BACKGROUND: Dienogest is a progestin with demonstrated efficacy in the treatment of endometriosis in European women. The objective of this study was to evaluate the efficacy and safety of dienogest in Chinese women. PATIENTS AND METHODS: Th…